Aignostics focuses on AI-powered precision diagnostics for pathology. Their mission is to support the discovery and validation of tissue-based biomarkers, and to develop them into diagnostic products for global use in clinics and labs. Aignostics' AI models are trained with clinical-grade data from multiple leading German institutes, and are developed side-by-side with experienced pathologists. Through their patented “Explainable AI” approach, they overcome conventional “black box” limitations of end-to-end AI models. Aignostics' proprietary cell detection and classification approach enables the further investigation of morphology and immune responses.